3,5-Diaethyl-isothiazol | 35610-84-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3,5-Diaethyl-isothiazol
• 英文别名: 3,5-diethyl-isothiazole；3,5-Diethyl-1,2-thiazole
• CAS: 35610-84-5
• 化学式: C₇H₁₁NS
• 分子量: 141.237
• InChiKey: KGTVWXIFRFMRQK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  41.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-Bromo-3,5-diethyl-1lambda4,2-dithiacyclopenta-3,5-diene 、 氨 以41%的产率得到
  参考文献：
  名称：

  COEN S.; POITE J.-C.; ROGGERO J.-P., BULL. SOC. CHIM. FRANCE, 1975, NO 3-4, PART. 2, 611-614

  摘要：

  DOI：

文献信息

• BENZOAZEPIN-OXY-ACETIC ACID DERIVATIVES AS PPAR-DELTA AGONISTS USED FOR THE INCREASE OF HDL-C, LOWER LDL-C AND LOWER CHOLESTEROL
  申请人：Janssen Pharmaceutica NV

  公开号：EP2010289B1

  公开（公告）日：2011-11-30
• Polycationic Compounds And Uses Thereof
  申请人：Mousa Shaker

  公开号：US20120322878A1

  公开（公告）日：2012-12-20

  Aspects of the present invention relate to compounds and methods useful in modulating angiogenesis and methods of treating or preventing diseases associated with angiogenesis by administering a polycationic compound. The present invention relates to methods of use and compositions for inhibiting angiogenesis-mediated disorders in mammals including animals and humans. Additionally, this invention relates to the combined use of polycations with other anti-angiogenesis agents for the treatment of different angiogenesis-mediated disorders. Additionally, those polycationic compounds can be used with various anti-inflammatory and cytotoxic agents as well as with radio-therapeutic agents in cancer patients to prevent and treat tumor growth and metastasis.
• US8507723B2
  申请人：——

  公开号：US8507723B2

  公开（公告）日：2013-08-13